Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

Figure 3 is missing the x-axis label and the indicators of significance. The authors have provided a corrected version of Figure 3 here.

thumbnail
Download:
Figure 3.

 Effect of IUGR and neonatal exendin-4 treatment on in vitro insulin secretion from isolated islets in response to glucose and potassium chloride. CON (white bar, n  =  5), IUGR+Veh (black bar, n  =  5) and IUGR+Ex-4 (gray bar, n  =  6). Data are means ± SEM. Specific contrasts: * P<0.05, # P<0.10.

https://doi.org/10.1371/journal.pone.0056553.g003

Reference

  1. 1. Gatford KL, Sulaiman SA, Mohammad SNB, De Blasio MJ, Harland ML, et al. (2013) Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb. PLoS ONE 8(2): e56553

Citation: The PLOS ONE Staff (2014) Correction: Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb. PLoS ONE 9(4): e95944. https://doi.org/10.1371/journal.pone.0095944

Published: April 25, 2014

Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.